Mr. Robert Meyer M.D. Director Office of Drug Evaluation II, Office of New DrugsCenter for Drug Evaluation and Research Food and Drug Administration Rockville, MD,
Safety of Imported Pharmaceuticals: Strengthening Efforts to Combat the Sales of Controlled Substances Over the Internet Subcommittee on Oversight and Investigations December 13, 2005 1:00 PM
Testimony is available in PDF format.
